ERBB2 and breast cancer: This is consistent with previous studies that have shown that the PI3K/AKT pathway is involved in the regulation of TZ response in HER2 + BC due to HER2/HER3 heterodimer formation which leads to the activation of this pathway (Junttila et al. 2009).